CareTalk: Healthcare. Unfiltered. · 2026-07-08 · 4 min
Send us Fan Mail There are very few cures for cancers that have already spread. So what does a good outcome actually look like? In this clip from our episode “How Targeted Radiotherapy Is Changing Cancer Care”, host David E. Williams and John Babich, Founder, President, and Chief Scientific Officer of Ratio Therapeutics, break down what extending life with quality really means in cancer care, and why giving someone eight more months where they can still live their life is the philosophy driving the work at Ratio Therapeutics. Listen to the full episode here ️️ABOUT JOHN BABICH John W. Babich, a native of New York City, holds a BS in pharmaceutical sciences from St. John’s University and a PhD in radiopharmaceutical chemistry from The Institute of Cancer Research in London. He began his career at Brookhaven National Laboratory and later NASA, focusing on cardiovascular imaging. Babich co-founded Molecular Insight Pharmaceuticals in 1998, where he developed several radiopharmaceuticals, including a PSMA inhibitor for prostate cancer now in Phase 3 trials. In 2017, he founded Noria Therapeutics, which was sold to Bayer in 2021, leading to the creation of Ratio Therapeutics.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Ben Bluml’s Case for the Connected Pharmacist There’s a Better Way · on healthcare89 / 100
Navigating High-Cost Claims: Employer Strategies for Managing Complex Healthcare Cases with Dr. Christine Hale, Chief Medical Officer, US Benefits at GallagherThe Benefits Playbook · on healthcare85 / 100
Success Leaves Clues: Ep 296 How Healthcare Innovation Improves Patient Access with John Leombruno, CEO at OkRx Success Leaves Clues with Robin Bailey and Al McDonald · on healthcare podcast79 / 100
AstraZeneca's CFO on GLP-1 Drugs, AI, and MoreAt Barron's · on Oncology78 / 100
US Pharma Deals Midyear Outlook 2026: Why Dealmakers Are Leaning Into GrowthPwC's Next in Health · on Oncology76 / 100
The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, NateraProgress, Potential, and Possibilities Podcast / Show · on Oncology65 / 100
How Consumers Are Defining Healthcare's Future w/ Dr. Daniel Kraft, Founder, NextMed Health81 / 100
AI and The Future Of Behavioral Health w/ Alon Joffe, Co-Founder & CEO, Eleos Health88 / 100
How Targeted Radiotherapy Is Changing Cancer Care w/ John Babich, President, CSO, Ratio Therapeutics94 / 100
Preparing for the Pandemic We Haven't Seen Yet w/ Dr. Dan Barouch & Kris Brown, Vector Sciences87 / 100Mark Cuban on Why Patients Don’t Trust Their Medical Bills85 / 100